BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Dizocilpine Maleate

A potent noncompetitive antagonist of the NMDA receptor (RECEPTORS, N-METHYL-D-ASPARTATE) used mainly as a research tool. The drug has been considered for the wide variety of neurodegenerative conditions or disorders in which NMDA receptors may play an important role. Its use has been primarily limited to animal and tissue experiments because of its psychotropic effects.

300+ PubMed studies analyzed · 1 RCTs · Evidence Score: 37.5

Research Domains

Dizocilpine Maleate has been studied across 21 research domains including 🧠 Memory, 🌤️ Mood & Depression, 🧠 Focus & Attention, 🧠 Neuroprotection, 🧘 Stress & Anxiety. The primary research focus is 🧠 Memory with 19% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Dizocilpine Maleate, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

D-Aspartic
7 shared targets
Aspartic
7 shared targets
Dextrorphan
7 shared targets
cycloserine
7 shared targets
Ibotenic
7 shared targets
Glycine
7 shared targets
Dextrothyroxine
7 shared targets
Levorphanol
7 shared targets
ifenprodil
4 shared targets
Dextromethorphan
7 shared targets
Loading evidence profile...

This evidence profile for Dizocilpine Maleate is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.